Mindstrong Health is a promising startup whose objective is to use smartphones to aid in detecting and also treating of ailments related to the brain or the human mind. The Chief Executive Officer of Mindstrong health says that the sort of objective measures put up for other chronic diseases such as diabetes needs to be put up also to advance the results from people with cognitive illnesses. Mindstrong developed a platform where they can measure brain functionality just by studying patients’ scrolling patterns and typing on smartphones. They intend to use factors like function, memory, and processing speed to acquire patient mood and cognition status.
Foresite Capital CEO and managing director, Jim Tananbaum, stated that the founding group for Mindstrong Health display clear and unparalleled comprehension of the serious complications. They encompass the way that the medical community handles patients with medical disorders. Jim says that by integrating leadership, experience, and technical vision, people concerned with improving patient results are granted an innovative forum that will transform the way in which care is given to patients with mental disorders. You can search him on Google
In the words, of Dr. Tom Insel, the co-founder of Mindstrong Health, not only is this invention a powerful one, but it also forms the foundation for the development of better inventions in transforming of health care for people with a mental health condition. Being that mental disorders are a worldwide health issue, the use of smartphones in health care should potentially contribute to a global solution.
This technological invention has secured a $14 million funding from Foresite Capital, ARCH Venture Partners, Optum Venture, and One Mind Health Impact Fund.
Jim Tananbaum Bio
Jim Tananbaum graduated from Harvard Medical School with an Doctor of Medicine, an Master of Business Administration from Harvard Business School, with a Bachelor of Science (B.S), and Bachelor of Science in electrical engineering from Yale University. He has served on the advisory board of Harvard-MIT HST program and Yale school of engineering.
His impact has been felt by the 21 successes achieved in the investments he led. Tananbaum has over 25 years of industrial experience. He had, previously in his career, been part of Prospect Venture Partners II and III. Jazz pharmaceutical, Amira Pharmaceuticals, Healtheon, and Amerigroup are some of his major investments.